The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

por Weng, Wayne, Kong, Sheldon X., Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd, Baeres, Florian M.M.
Publicado 2020

Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

por Yale, Jean-François, Damci, Taner, Kaiser, Marcel, Karnieli, Eddy, Khunti, Kamlesh, Liebl, Andreas, Baeres, Florian MM, Svendsen, Anne Louise, Ross, Stuart A
Publicado 2013

LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

por Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
Publicado 2014

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

por Petrie, John R., Marso, Steven P., Bain, Stephen C., Franek, Edward, Jacob, Stephan, Masmiquel, Luis, Leiter, Lawrence A., Haluzik, Martin, Satman, Ilhan, Omar, Mohamed, Shestakova, Marina, Van Gaal, Luc, Mann, Johannes F., Baeres, Florian M.M., Zinman, Bernard, Poulter, Neil R.
Publicado 2016